Role of C3a and C5a in the activation of mast cells

A. Erdei, Krisztina Kerekes, Israel Pecht

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Mast cells and basophils are known to be triggered by allergens via cross-linking with their high-affinity IgE-binding receptors, FcεRI. The anaphylatoxic activity of the complement-derived peptides C3a and C5a has been known for a long time; however, it has also been reported that serosal- and mucosal-type mast cells respond differently to peptidergic stimuli. The mechanism of mast cell activation by cross-linking of FcεRI has been the subject of intensive studies in the past few years, while the action mode of the anaphylatoxic complement peptides has been revealed only recently. We report about a novel function of C3a: its inhibitory activity on IgE-mediated triggering of the mucosal RBL-2H3 cells. Surprisingly, the other anaphylatoxic peptide C5a, which has been shown to be significantly more effective in several biological assays, did not influence antigen-induced triggering of the RBL-2H3 cell line at all.

Original languageEnglish
Pages (from-to)16-18
Number of pages3
JournalExperimental and Clinical Immunogenetics
Volume14
Issue number1
Publication statusPublished - 1997

Fingerprint

Mast Cells
Peptides
IgE Receptors
Basophils
Biological Assay
Allergens
Immunoglobulin E
Antigens
Cell Line

Keywords

  • C3a
  • C5a
  • FcεRI
  • Inhibition
  • RBL-2H3 cells
  • Triggering

ASJC Scopus subject areas

  • Immunology
  • Genetics(clinical)
  • Genetics

Cite this

Role of C3a and C5a in the activation of mast cells. / Erdei, A.; Kerekes, Krisztina; Pecht, Israel.

In: Experimental and Clinical Immunogenetics, Vol. 14, No. 1, 1997, p. 16-18.

Research output: Contribution to journalArticle

Erdei, A. ; Kerekes, Krisztina ; Pecht, Israel. / Role of C3a and C5a in the activation of mast cells. In: Experimental and Clinical Immunogenetics. 1997 ; Vol. 14, No. 1. pp. 16-18.
@article{17d57409573d428c82ba786968e72461,
title = "Role of C3a and C5a in the activation of mast cells",
abstract = "Mast cells and basophils are known to be triggered by allergens via cross-linking with their high-affinity IgE-binding receptors, FcεRI. The anaphylatoxic activity of the complement-derived peptides C3a and C5a has been known for a long time; however, it has also been reported that serosal- and mucosal-type mast cells respond differently to peptidergic stimuli. The mechanism of mast cell activation by cross-linking of FcεRI has been the subject of intensive studies in the past few years, while the action mode of the anaphylatoxic complement peptides has been revealed only recently. We report about a novel function of C3a: its inhibitory activity on IgE-mediated triggering of the mucosal RBL-2H3 cells. Surprisingly, the other anaphylatoxic peptide C5a, which has been shown to be significantly more effective in several biological assays, did not influence antigen-induced triggering of the RBL-2H3 cell line at all.",
keywords = "C3a, C5a, FcεRI, Inhibition, RBL-2H3 cells, Triggering",
author = "A. Erdei and Krisztina Kerekes and Israel Pecht",
year = "1997",
language = "English",
volume = "14",
pages = "16--18",
journal = "Experimental and Clinical Immunogenetics",
issn = "0254-9670",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Role of C3a and C5a in the activation of mast cells

AU - Erdei, A.

AU - Kerekes, Krisztina

AU - Pecht, Israel

PY - 1997

Y1 - 1997

N2 - Mast cells and basophils are known to be triggered by allergens via cross-linking with their high-affinity IgE-binding receptors, FcεRI. The anaphylatoxic activity of the complement-derived peptides C3a and C5a has been known for a long time; however, it has also been reported that serosal- and mucosal-type mast cells respond differently to peptidergic stimuli. The mechanism of mast cell activation by cross-linking of FcεRI has been the subject of intensive studies in the past few years, while the action mode of the anaphylatoxic complement peptides has been revealed only recently. We report about a novel function of C3a: its inhibitory activity on IgE-mediated triggering of the mucosal RBL-2H3 cells. Surprisingly, the other anaphylatoxic peptide C5a, which has been shown to be significantly more effective in several biological assays, did not influence antigen-induced triggering of the RBL-2H3 cell line at all.

AB - Mast cells and basophils are known to be triggered by allergens via cross-linking with their high-affinity IgE-binding receptors, FcεRI. The anaphylatoxic activity of the complement-derived peptides C3a and C5a has been known for a long time; however, it has also been reported that serosal- and mucosal-type mast cells respond differently to peptidergic stimuli. The mechanism of mast cell activation by cross-linking of FcεRI has been the subject of intensive studies in the past few years, while the action mode of the anaphylatoxic complement peptides has been revealed only recently. We report about a novel function of C3a: its inhibitory activity on IgE-mediated triggering of the mucosal RBL-2H3 cells. Surprisingly, the other anaphylatoxic peptide C5a, which has been shown to be significantly more effective in several biological assays, did not influence antigen-induced triggering of the RBL-2H3 cell line at all.

KW - C3a

KW - C5a

KW - FcεRI

KW - Inhibition

KW - RBL-2H3 cells

KW - Triggering

UR - http://www.scopus.com/inward/record.url?scp=0030892284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030892284&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 16

EP - 18

JO - Experimental and Clinical Immunogenetics

JF - Experimental and Clinical Immunogenetics

SN - 0254-9670

IS - 1

ER -